Thus chordin is a modifier for the craniofacial anomalies of Tbx1 mutations, demonstrating the existence of a second-site modifier for a specific subset of phenotypes associated with 22q11DS. This evidence concerns the gene CHRD and 22q11.2 deletion syndrome.